BL
Belite Bio, Inc (BLTE)
NASDAQ·Healthcare·Biotechnology
$144.98
+4.73%
Mkt Cap $6.72B
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$203.00
Range $187.00 – $223.00
Implied Upside
+40.0%
Consensus $203.00 vs current $144.98
NASDAQ·Healthcare·Biotechnology
$144.98
+4.73%
Mkt Cap $6.72B
No recent rating data.
Price Target (10 analysts)
$203.00
Range $187.00 – $223.00
+40.0%
Consensus $203.00 vs current $144.98